[Penetration and persistence of rifampicin at the tissue and lesion level].
D001826:Body Fluids / Q000032:analysis; D001980:Bronchi / Q000378:metabolism; D001996:Bronchopneumonia / Q000188:drug therapy; D006801:Humans; D008168:Lung / Q000378:metabolism; D008171:Lung Diseases / Q000188:drug therapy*; D008175:Lung Neoplasms / Q000188:drug therapy*; D010994:Pleura / Q000378:metabolism; D010998:Pleurisy / Q000188:drug therapy; D012293:Rifampin / Q000378:metabolism* / Q000627:therapeutic use; D014390:Tuberculosis, Meningeal / Q000188:drug therapy; D014396:Tuberculosis, Pleural / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D012293:Rifampin
Penetrazione e persistenza della Rifampicina a livello tessutale e lesionale